Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer-oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical knowhow of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

 

Top

Board of Directors

Solara Active Pharma Sciences / Board of Directors
Aditya Puri

Aditya Puri

Chairman

LEARN MORE
Dr. Kausalya Santhanam

Dr. Kausalya Santhanam

Independent Director

LEARN MORE
Ramakrishnan R.

Ramakrishnan R

Independent Director and Audit Committee Chairman

LEARN MORE
Nirmal Bhogilal

Nirmal Bhogilal

Independent Director

LEARN MORE
Arun Kumar

Arun Kumar

Founder & Non-Executive Director

LEARN MORE
Ankur Thadani

Ankur Thadani

Non-Executive Director

LEARN MORE
Kartheek Chintalapathi Raju

Kartheek Raju

Non-Executive Director

LEARN MORE
Rajender Rao Juvvadi

Rajender Rao Juvvadi

Executive Director & Vice Chairman

LEARN MORE
Bharath

Bharath.R.Sesha

Managing Director & Chief Executive Officer

LEARN MORE
Subhash

Subhash Anand

Executive Director Finance & CFO

LEARN MORE
Aditya Puri

Aditya Puri

Chairman

Recognized as a stalwart of the Indian banking and financial services industry, Mr. Puri was the iconic Founder-Managing Director and Chief Executive Officer of HDFC Bank from its inception in 1994 until his retirement from the position in October 2020, earning the distinction of having been the longest serving head of a private bank in India.

Not only was Mr. Puri’s visionary leadership instrumental in HDFC Bank’s outstanding growth and value creation for all stakeholders, but it also led the way for several firsts and milestones for Indian private sector banking as a whole.

Prior to setting up HDFC Bank, he was Chief Executive Officer of Citibank Malaysia with nearly two decades of overall banking experience across markets with Citibank. Mr. Puri has been conferred with several prestigious awards, accolades and titles for his exceptional contribution to Indian industry, including successive appearances in Barron’s world’s 30 best CEOs lists.

Mr. Puri was inducted into the Chartered Accountants Hall of Fame by the Institute of Chartered Accountants of India (ICAI), becoming the first member of ICAI to be honored with this award. A profile by the Economist in October 2020 describing him as the world’s best banker only further underscored Mr. Puri’s towering international reputation.

Arun Kumar

Arun Kumar

Founder and Non-Executive Director

Arun Kumar is a first-generation entrepreneur and is known for his intellect of picking “difficult to operate” domains with high scarcity value. He founded Strides Pharma Science Limited (Strides) in 1990 and has since led the company in building a global reputation with a differentiated business model and delivering value for its stakeholders
(Over $5.0 billion value creation for shareholders while holding the corporate record for the most extensive dividend distribution in India).

Besides founding Strides, Arun’s family office (Setup in the early 2000s) run a
differentiated set of investments spread across several companies with a combined
revenue base over a billion dollars and an invested capital over half a billion dollars.
Arun is credited to have co-founded and built India’s largest fully integrated Animal
Health Company – SeQuent (recently sold to Carlyle) and founded & built Solara to
become India’s second largest Active Pharmaceutical Ingredient (API) in under four
years.

In partnership with TPG, Arun founded Stelis Biopharmaceuticals and Steriscence a
specialty injectable platform. Stelis Biopharmaceuticals is a fully integrated CDMO
with capabilities in Mammalian, Microbial and Viral Vector vaccines and has recently
invested in mRNA & DNA platform technologies.

The businesses run under Arun’s leadership / ownership have a presence in 100+
countries with 7000+ employees with over 30 global manufacturing facilities.
Arun is a recipient of E&Y Entrepreneur of the year award in the Healthcare sector in
2000. He has also been awarded the Business Today “India Best CEO Award (Mid-
Sized Companies Category)” and the “Best CEO in the Pharma & Healthcare Industry”
in 2014.

Kartheek Chintalapathi Raju

Kartheek Raju

Non-Executive Director

Mr. Kartheek Chintalapati Raju has over ten years of experience in Investment and Consulting. At iLabs, he focuses on investments across Pharma, Power, and Commercial Real Estate sectors.

He is passionate about identifying opportunities and has worked closely with the Founders in scaling up the operations and putting the companies on a higher growth trajectory.
Under Special Situations Platform of iLabs, Kartheek has played a pivotal role in acquiring distressed assets in Power, Pharma, Real Estate and Defense sectors, and worked with the Management in transforming them into profitable ventures.

Kartheek holds a Bachelor of Business Administration Degree in Economics, Accounts and Finance from Claremont McKenna College. Prior to iLabs Group, Kartheek was a Business Analyst at McKinsey & Company’s Dubai Office.

In his spare time, he enjoys sports and adventure activities which include polo, skiing, biking, and sailing.

Rajender Rao Juvvadi

Rajender Rao Juvvadi

Executive Director & Vice Chairman

Rajendra Rao commenced his professional career with Reliance Industries Ltd. Handling exports of Liquids. From the 1996 to 1998, he was an integral part of Nicholas Piramal Ltd. Through the years he began taking multi-functional responsibilities, which laid the foundation for a learning and understanding of all facets of business. He went on to initiate Pharma trading in the year 1998 and later graduated into manufacturing from contracted facilities, until the year 2003.

He then started Ra Chem Pharma, when the first manufacturing facility was acquired and the journey of Ra Chem pharma ltd commenced. Other promoter shareholders and industry professionals joined the fray at this stage with Raj being at the helm. He transformed the loss-making acquisition into a viable profit-making unit within a span of two years.

He recognized an integrated vertical model as the essence of success and value creation in pharma – a move that initiated a series of acquisitions and amalgamations. This resulted in creation of an API, FDF and a Bio analytical and bio equivalence study facility completing the vertical integration. He then focused on organic growth thereafter led to business consolidation and building of teams of integrity, competencies and abilities

Owing to a widely dispersed shareholding with varying perceptions on the growth to be pursued, Raj envisions aggressive growth plans for his new ventures and new entity, Aurore Life Sciences Pvt Ltd.

Deepak Vaidya

Deepak Vaidya

Chairman & Non-Executive Director

Mr. Deepak Vaidya is a fellow member of the Institute of Chartered Accountants in England and Wales. He has previously worked as the Country Head of Schroder Capital Partners (Asia) Pte. Ltd. for over 12 years. He is experienced in the corporate financial services industry in India and abroad. He is holding directorship in reputed companies.

Nirmal Bhogilal

Nirmal Bhogilal

Independent Director

Mr. Nirmal Bhogilal is the Chairman of the Batliboi Group. The Group’s operations are in Machine Tools, Textile Machinery, Air Engineering & Pollution Control Equipment, Rotating Machines, Wind Energy and Logistics.

He was Past President and currently a Committee Member of the Indian Machine Tool Manufacturers Association (IMTMA). He has been Chairman of various committees in the Confederation of Indian Industry (CII) at the National & Western Region levels and is currently a member of the CII National Council. He is a Committee Member and Past President of Indo German Chamber of Commerce.

He is also a Committee Member of the Forum of Free Enterprise and a Council Member of the National Centre for the Performing Arts (NCPA). He is an Independent Director of Chowgule Industries Pvt. Ltd. and Eimco Elecon (I) Ltd.

Ramakrishnan R.

Ramakrishnan R.

Independent Director and Audit Committee Chairman

Mr. R Ramakrishnan is a Fellow Member of The Institute of Chartered Accounts of India and also a Law Graduate from Bangalore University. He is a practicing Chartered Accountant and a Management Consultant at Bangalore having an experience of 36 years in Direct tax matters, Audit and Assurances. He was nominated by KSIIDC for few listed Companies and currently holds directorships in reputed companies.
He is also a Managing Trustee for RRK Foundation – a foundation financially supporting more than 100 students for Higher Secondary School to economically weaker sections and Trustee for few philanthropic organizations.
He is an Independent Director and Audit Committee Chairman of the Company.

Dr. Kausalya Santhanam

Dr. Kausalya Santhanam

Independent Director

 

Dr. Kausalya Santhanam, Founder of SciVista IP & Communication (www.scivistaip.com), is a Patent attorney registered with the Indian Patent Office as well as the US Patent and Trademark Office and Indian Patent Office. She has a Ph.D. in Cell Biology and Immunology from Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh. Her Post-Doctoral training was in Cancer Biology at Center for Cellular and Molecular Biology (CCMB), Hyderabad, where she has published her studies in peer-reviewed journals. Later she went as a National Research Council (NRC) Fellow to Walter Reed Army Institute of Research, Washington DC where her studies involved molecular mechanisms of inflammation. Following that, at Albert Einstein College of Medicine, New York, she worked towards understanding the mechanisms of an apoptotic molecule. All the research work have been published in reputed journals. Later, she worked for five years in the Intellectual Property Department of CuraGen Corporation, a Biopharmaceutical company at Connecticut, USA. She is an Independent Director of the Company.

Ron de Vries

Ronald Tjeerd de Vries (Ron)

Independent Director

Mr. Ronald Tjeerd de Vries (Ron) is a MsC in Chemical Engineering and IMD executive Leadership Alumni. He has 25 years’ experience in the MNC Corporate Sector in Pharma and Food Presently he is Owner and MD of RDV Consulting based at Auckland (NZ).

Ankur Thadani

Ankur Thadani

Non-Executive Director

Mr. Ankur Thadani is a Principal at TPG Growth, based in Mumbai. He joined TPG in 2013 and has worked on multiple investments in Healthcare, Energy and Consumer sectors across India and the broader South-Asia region. Ankur also serves on the board of CTSI, Rhea Healthcare, Fourth Partner Energy and Asiri Hospitals. Prior to joining TPG, he worked with an Indian private equity fund, India Equity Partners, focusing on investments in consumer and healthcare sectors. Ankur received his MBA from IIFT, where he was awarded a Gold Medal for all-round achievement.

Bharath

Bharath.R.Sesha

MD & Chief Executive Officer

Bharath has over two decades of experience across diverse industries. His expertise spans across the pharmaceutical, healthcare and material sciences industries. He has operated in countries like USA, Hongkong, China, Middle East, Africa and Europe. He has held CXO level positions in companies like DSM Sinochem Pharmaceuticals and Royal DSM NV. During the course of his career Bharath has led organizations through transformative growth. He has had particular success in putting together well thought out strategies and setting up winning teams that have delivered excellent results. At Solara, Bharath will focus on leveraging its unique strengths and abundant human talent in building a successful and growing company. Bharath is an Engineering graduate with a management degree from the Institute for Technology and Management, Chennai. He also has a master’s degree in International Management from Thunderbird School of Global Management, United States.

Subhash

Subhash Anand

Executive Director & Chief Financial Officer

With experience over three decades in Multinational and Indian companies, Subhash has extensive experience in Operational & strategic finance. In his earlier roles, he was involved in M&A projects, Equity raise, margin expansion, prioritizing investment and generating free cashflow. He has partnered across the business that led various projects like SAP implementations, GST transitions, Digital finance, Shared Services for global finance operations. Subhash brings a wealth of experience across Margin expansion, the full array of the finance function including Treasury, Investor relations, Strategy development and deployment, financial planning & analysis, shared services, controllership, secretarial and taxation.

Subhash is a qualified AICWA (India) & Certified Management Accountant (CMA) from the Institute of Management Accountants (USA) with 30+ years of managerial and professional experience. His last held position was as President & CFO at PI Industries Ltd (PIIL). Prior to PIIL, he worked in Whirlpool, Sterlite Industries, Hindustan Copper Ltd and Calcom in senior finance roles.